Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
MEDICINOVA INC (MNOV)
|
Add to portfolio |
|
|
|
| Price: |
$4.55
| | Metrics |
| OS: |
49.0
|
M
| |
|
|
| Market cap: |
$223
|
M
| |
|
|
|
Net cash:
|
$52.9
|
M
| |
$1.08
|
per share
|
|
EV:
|
$170
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 4.0 | 14.2 | 14.0 | 15.6 | 13.0 | 10.9 | 9.1 | 9.6 |
| Revenue growth | -71.5% | 1.0% | -10.0% | 19.6% | 19.7% | 19.3% | -5.2% | 60.3% |
| Cost of goods sold | 14.3 | 14.2 | 14.0 | 15.6 | 13.0 | 10.9 | 0.3 | 0.4 |
| Gross profit | -10.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 8.8 | 9.2 |
| Gross margin | -253.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 96.7% | 95.8% |
| Research and development | | | | | | | | |
| General and administrative | 5.7 | 6.7 | 8.0 | 10.0 | 8.8 | 7.4 | 5.8 | 6.0 |
| EBIT | -10.2 | -14.2 | -14.0 | -15.6 | -13.0 | -10.9 | -8.8 | -9.2 |
| EBIT margin | -253.0% | -100.0% | -100.0% | -100.0% | -100.0% | -100.0% | -96.7% | -95.8% |
| Pre-tax income | -10.1 | -13.9 | -12.9 | -14.7 | -12.9 | -10.9 | -8.8 | -9.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | -1.7 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 0.0% | | | 13.5% | | | 0.0% |
| Net income | -10.1 | -13.9 | -12.9 | -14.7 | -11.2 | -10.9 | -8.8 | -9.2 |
| Net margin | -251.0% | -97.7% | -92.2% | -94.2% | -85.7% | -99.9% | -97.0% | -95.6% |
| |
| Diluted EPS | ($0.21) | ($0.31) | ($0.30) | ($0.36) | ($0.32) | ($0.33) | ($0.33) | ($0.38) |
| Shares outstanding (diluted) | 48.6 | 44.4 | 43.2 | 41.1 | 35.1 | 33.0 | 26.6 | 24.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|